However, the frequencies of these mutations are very low in certain malignancies such as HCC, wherein CTNNB1 mutation rate was 12%–16%, AXIN mutation rate was 8%–15%, and no mutation of APC was reported [43,44]. Here, CTNNB1 is linked to hepatocellular carcinoma.